treatment of trochanteric femur fractures
Conditions
Interventions
Sixty patients, age >60 years, with an AO31-A2 type trochanteric fracture will be randomly allocated to treatment with either DHS or Gamma-nail.
Intervention: Micromotion across the fracture site (
Sponsors
Leiden University Medical Centre (LUMC)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged over 60; 2. AO31-A2 type trochanteric fracture; 3. Informed consent.
Exclusion criteria
Exclusion criteria: 1. Aged under 60; 2. AO31-A1 or A3 type trochanteric fracture; 3. No informed consent; 4. Severe arthritis of the involved hip; 5. Reumatoid arthritis; 6. Pathological fracture; 7. Pre-existent immobility.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameters/endpoints: Parameters: Demographical data, co-morbidity, rotation and translation as determined on RSA radiographs, type of implant: intra-, or extra-medullary, position of the femoral head screw, bone density and adverse events. Primary endpoint: Rotation and translation as determined on RSA radiographs in relation to type of implant used: intra-, or extra-medullary. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: Micromotion in relation to the position of the femoral head screw and bone density. Local adverse events (cut-out, implant failure). | — |
Contacts
Public ContactI.B. Schipper
Erasmus Medical Center, Trauma Center ZWN, room Z-9.15, P.O. Box 2040
Outcome results
None listed